danofloxacin has been researched along with Lung Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, Y; Li, Z; Tang, X; Wang, X; Zhao, Y; Zhou, Y | 1 |
1 other study(ies) available for danofloxacin and Lung Neoplasms
Article | Year |
---|---|
LZ-101, a novel derivative of danofloxacin, induces mitochondrial apoptosis by stabilizing FOXO3a via blocking autophagy flux in NSCLC cells.
Topics: A549 Cells; Animals; Anti-Infective Agents; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Fluoroquinolones; Forkhead Box Protein O3; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Proteasome Endopeptidase Complex; Xenograft Model Antitumor Assays | 2019 |